Leading the Way in Life Science Technologies

GEN Exclusives

More »

Feature Articles

More »

For full access to this article login to GEN Select now.

November 01, 2007 (Vol. 27, No. 19)

Fragment-Based Discovery in Spotlight

FBDD Research Is Increasingly Targeting Protein-Protein Interactions

  • Many drug discovery researchers think smaller these days, specifically about fragments. “A big trend more specific to small molecule drug discovery is fragment-based drug design (FBDD),” said Molly He, Ph.D., senior scientist at Sunesis Pharmaceuticals (www.sunesis.com). “It has gained increasing popularity among the pharmaceutical and biotech companies because of ...

Not registered yet? Please fill out the form below and enjoy complimentary access to this and an exclusive collection of premium content and personalization features as a GEN Select insider. Learn More.

Get GEN Select Access Now

    • Do not put any letters or characters here if you are not a spy program.